Diagnostic accuracy of CCTA-derived versus angiography-derived quantitative flow ratio (CAREER) study : a prospective study protocol
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
INTRODUCTION: Coronary CT angiography (CCTA)-derived quantitative flow ratio (CT-QFR) is a novel non-invasive technology to assess the physiological significance of coronary stenoses, which enables fast and on-site computation of fractional flow reserve (FFR) from CCTA images. The objective of this investigator-initiated, prospective, single-centre clinical trial is to evaluate the diagnostic performance of CT-QFR with respect to angiography-derived QFR, using FFR as the reference standard.
METHODS AND ANALYSIS: A total of 216 patients who have at least one lesion with a diameter stenosis of 30%-90% in an artery with ≥2.0 mm reference diameter will be enrolled in the study. FFR will be measured during invasive coronary angiography. CT-QFR and QFR will be assessed in two independent core laboratories in a blinded fashion. The primary endpoint is the diagnostic accuracy of CT-QFR in identifying haemodynamically significant coronary stenosis with FFR as the reference standard. The major secondary endpoint is the non-inferiority of CT-QFR compared with QFR in the patients without extensively calcified lesions.
ETHICS AND DISSEMINATION: The study was approved by the Ethics Committee of Huadong Hospital Affiliated to Fudan University (2020K192). Outcomes will be disseminated through publications in peer-reviewed journals and presentations at scientific conferences.
TRIAL REGISTRATION NUMBER: NCT04665817.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
BMJ open - 12(2022), 6 vom: 23. Juni, Seite e055481 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Weng, Tingwen [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adult cardiology |
---|
Anmerkungen: |
Date Completed 27.06.2022 Date Revised 16.07.2022 published: Electronic ClinicalTrials.gov: NCT04665817 Citation Status MEDLINE |
---|
doi: |
10.1136/bmjopen-2021-055481 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM342597485 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM342597485 | ||
003 | DE-627 | ||
005 | 20231226204903.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/bmjopen-2021-055481 |2 doi | |
028 | 5 | 2 | |a pubmed24n1141.xml |
035 | |a (DE-627)NLM342597485 | ||
035 | |a (NLM)35738652 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Weng, Tingwen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Diagnostic accuracy of CCTA-derived versus angiography-derived quantitative flow ratio (CAREER) study |b a prospective study protocol |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.06.2022 | ||
500 | |a Date Revised 16.07.2022 | ||
500 | |a published: Electronic | ||
500 | |a ClinicalTrials.gov: NCT04665817 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
520 | |a INTRODUCTION: Coronary CT angiography (CCTA)-derived quantitative flow ratio (CT-QFR) is a novel non-invasive technology to assess the physiological significance of coronary stenoses, which enables fast and on-site computation of fractional flow reserve (FFR) from CCTA images. The objective of this investigator-initiated, prospective, single-centre clinical trial is to evaluate the diagnostic performance of CT-QFR with respect to angiography-derived QFR, using FFR as the reference standard | ||
520 | |a METHODS AND ANALYSIS: A total of 216 patients who have at least one lesion with a diameter stenosis of 30%-90% in an artery with ≥2.0 mm reference diameter will be enrolled in the study. FFR will be measured during invasive coronary angiography. CT-QFR and QFR will be assessed in two independent core laboratories in a blinded fashion. The primary endpoint is the diagnostic accuracy of CT-QFR in identifying haemodynamically significant coronary stenosis with FFR as the reference standard. The major secondary endpoint is the non-inferiority of CT-QFR compared with QFR in the patients without extensively calcified lesions | ||
520 | |a ETHICS AND DISSEMINATION: The study was approved by the Ethics Committee of Huadong Hospital Affiliated to Fudan University (2020K192). Outcomes will be disseminated through publications in peer-reviewed journals and presentations at scientific conferences | ||
520 | |a TRIAL REGISTRATION NUMBER: NCT04665817 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a adult cardiology | |
650 | 4 | |a cardiomyopathy | |
650 | 4 | |a coronary heart disease | |
650 | 4 | |a coronary intervention | |
650 | 4 | |a ischaemic heart disease | |
700 | 1 | |a Gan, Qian |e verfasserin |4 aut | |
700 | 1 | |a Li, Zehang |e verfasserin |4 aut | |
700 | 1 | |a Guan, Shaofeng |e verfasserin |4 aut | |
700 | 1 | |a Han, Wenzheng |e verfasserin |4 aut | |
700 | 1 | |a Zhai, Xinrong |e verfasserin |4 aut | |
700 | 1 | |a Li, Ming |e verfasserin |4 aut | |
700 | 1 | |a Qi, Lin |e verfasserin |4 aut | |
700 | 1 | |a Li, Cheng |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yang |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Liang |e verfasserin |4 aut | |
700 | 1 | |a Chang, Xifeng |e verfasserin |4 aut | |
700 | 1 | |a Tu, Shengxian |e verfasserin |4 aut | |
700 | 1 | |a Qu, Xinkai |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMJ open |d 2012 |g 12(2022), 6 vom: 23. Juni, Seite e055481 |w (DE-627)NLM215724372 |x 2044-6055 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2022 |g number:6 |g day:23 |g month:06 |g pages:e055481 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjopen-2021-055481 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2022 |e 6 |b 23 |c 06 |h e055481 |